Integrating Sexual Partners into Pharmacological Sex Therapy

Conaglen, Helen M.; Conaglen, John V.

doi:10.1002/9781118510384.ch28

Cited by 2 publications

(1 citation statement)

References 110 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Under these circumstances, stimulation of sexual responsiveness with medication cannot be expected to have much positive effect. Therefore, it should be strongly recommended to treat the couple rather than only the woman with low sexual interest and arousal problems and to embed psychopharmacological intervention in cognitive behavioral and sex therapy interventions [ 41 •].…”

Section: Recent Developments In Psychopharmacological Treatment Of Fsmentioning

confidence: 99%

Recent Developments in Psychopharmaceutical Approaches to Treating Female Sexual Interest and Arousal Disorder

Both

2017

Curr Sex Health Rep

View full text Add to dashboard Cite

Purpose of ReviewThis review summarizes the recent literature and empirical studies on psychopharmacological approaches to treating female sexual interest/arousal disorder (FSIAD).Recent FindingsSeveral new drugs for FSIAD that are intended to increase sexual responsiveness by influencing central excitatory and inhibitory neuromodulatory processes are under development. Studies on flibanserin resulted in the first approved medication for the treatment of low sexual desire in premenopausal women. New drugs under development are testosterone combined with sildenafil or buspiron, bremelanotide, BP101, and nasal testosterone (TBS-2).SummaryAlthough pharmacological enhancement of sexual responsiveness may be potentially helpful in the treatment of FSIAD, the observed effects of flibanserin and other new drugs under development seem limited in terms of clinical significance. Given the multifactorial character of FSIAD, it may be important to integrate psychopharmacological treatment with sex therapy for optimal treatment efficacy.

show abstract

Section: Recent Developments In Psychopharmacological Treatment Of Fsmentioning

confidence: 99%